If a doctor once told you your symptoms didn't quite fit IBS, the new Rome V criteria are worth revisiting. The criteria for irritable bowel syndrome changed in 2026, broadening the definition in two ways while narrowing it in another.
Some people who fell outside the old thresholds may now qualify. The line moved, but that doesn't mean everyone was previously misdiagnosed. Here's what changed, what early research found, and when symptoms deserve medical attention.
How Is IBS Diagnosed?
There is no single test that confirms IBS. Diagnosis relies on your symptom pattern, a clinical assessment, and testing when needed to rule out other causes.
The Rome criteria provide a standardized definition developed by experts in digestive health. Rome IV was published in 2016. Rome V replaced it in 2026, with the bowel disorders chapter that contains the IBS criteria appearing online in February and in print in May. The Rome Foundation's Rome V books followed in June.
Rome IV used the term disorders of gut-brain interaction, which Rome V retains. The term reflects communication between the digestive system and the nervous system. It doesn't mean symptoms are imaginary or lack a biological basis.
What Are the Rome V Criteria for IBS?
The criteria describe a symptom pattern. Meeting them alone does not establish a diagnosis.
- Recurrent abdominal pain or discomfort: An average of at least three days per month over the past three months.
- At least two of three associations: The pain or discomfort relates to a bowel movement, a change in stool frequency, or a change in stool form.
- Symptom duration: Symptoms must have started at least six months before diagnosis.
- Menstrual symptoms: Rome V lists as a supportive criterion that abdominal pain or discomfort should not be related only to menstruation. Symptoms around a period don't automatically rule out IBS or establish a gynecologic diagnosis.
Rome V also distinguishes recurrent pain from continuous pain. It publishes the criteria in two versions, one for research and one for clinical practice.
What Changed From Rome IV?
There are three major changes. Two changes broaden the definition. The third makes it more restrictive.
Discomfort Counts Again
Rome IV required abdominal pain and excluded discomfort, partly because the term is interpreted differently across languages and cultures. Rome V includes both pain and discomfort.
The Frequency Threshold Is Lower
Rome IV required symptoms at least one day per week. Rome V lowers the threshold to an average of three days per month, allowing some people with less frequent symptoms to qualify.
Continuous Pain Is Excluded
Rome V requires recurrent rather than continuous abdominal pain or discomfort. People whose symptoms otherwise resemble IBS can fall outside the definition on this point alone.
What Does the Continuous-Pain Rule Mean?
Continuous abdominal pain is also a feature of centrally mediated abdominal pain syndrome (CAPS), a separate condition involving persistent pain. Continuous pain alone does not establish CAPS, which has criteria of its own. A clinician has to assess the full symptom pattern and consider other causes.
Among patients at one Leeds clinic diagnosed with IBS who did not meet Rome V, more than 70% missed on this point alone, reporting continuous daily pain. What fits those patients instead may be another condition, or may stay unexplained.
What Did the First Rome V Studies Find?
Two early studies examined the revised criteria. One looked at how they classify people who already report having IBS. The other tested how well they perform in a specialist clinic. The findings answer different questions and are not in conflict.
A UK Survey Found More People Met Rome V Than Rome IV
A UK survey of adults who self-reported IBS applied Rome III, IV, and V criteria. Of 1,275 respondents with complete data, 78% met Rome III criteria, 59% met Rome IV, and 70% met Rome V.
Compared with those meeting Rome IV, respondents meeting Rome V reported less severe symptoms, less psychological comorbidity, better quality of life, and less disruption to work and social activities. Classification was also less stable over 12 months, meaning more people moved in and out of the criteria.
Symptoms fluctuate, and people near a threshold may cross it over time. The findings describe this survey group, not the general population, and self-reported IBS is not the same as a clinician-confirmed diagnosis.
A Specialist-Clinic Study Found Lower Sensitivity
A second study evaluated 726 patients at a specialist clinic in Leeds, UK. Rome V identified fewer patients with IBS than earlier versions: its sensitivity was 66.1%, compared with 78.9% for Rome IV and 87.5% for Rome III.
Specificity, which measures how well criteria exclude people without IBS, was similar for Rome V and Rome IV: 80.1% versus 81.0%.
One specialist clinic cannot settle how the criteria behave elsewhere, and its patients were already referred for suspected IBS. The authors said the clinical significance of Rome V's lower sensitivity remains uncertain.
How to Talk to Your Doctor About IBS
A clear description of your symptoms helps your doctor decide whether IBS fits and whether testing makes sense.
Track the basics. Note when pain or discomfort occurs, how often you have bowel movements, and changes in stool form. A few weeks of notes can help, but don't delay an appointment to collect data.
Describe the pain accurately. Explain whether it comes and goes or feels continuous. Use your own words rather than trying to fit your experience into a diagnostic label.
Mention relevant family history. Tell your doctor about relatives with colorectal cancer, inflammatory bowel disease, or celiac disease. These histories have different implications, and details such as a relative's age at colorectal cancer diagnosis can affect screening recommendations.
Ask what tests make sense. IBS is often diagnosed positively from symptoms rather than through exhaustive testing. Testing may still be appropriate based on your symptoms and risk factors. For example, the ACG clinical guideline recommends fecal calprotectin for people with suspected IBS and diarrhea who have no alarm features, helping distinguish IBS from inflammatory bowel disease.
Celiac disease, microscopic colitis, bile acid diarrhea and thyroid problems can all cause overlapping symptoms.
